Evidence map›Paper›PMID 27775644›Full record

ArticleMicroarrays (Basel, Switzerland)2016

Computational Modeling and Analysis of Microarray Data: New Horizons.

Heather J Ruskin

Abstract readEditorial
In one paragraph

Article in Microarrays (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A weighted ensemble-based active learning model to label microarray data.Medical & biological engineering & computing · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Heather J RuskinSci-Sym Centre (Scientific Computing & Complex Systems Modelling), School of Computing, Dublin City University, Dublin 9, Ireland. Heather.Ruskin@dcu.ie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput microarray technologies have long been a source of data for a wide range of biomedical investigations. Over the decades, variants have been developed and sophistication of measurements has improved, with generated data providing both valuable insight and considerable analytical challenge. The cost-effectiveness of microarrays, as well as their fundamental applicability, made them a first choice for much early genomic research and efforts to improve accessibility, quality and interpretation have continued unabated. In recent years, however, the emergence of new generations of sequencing methods and, importantly, reduction of costs, has seen a preferred shift in much genomic research to the use of sequence data, both less 'noisy' and, arguably, with species information more directly targeted and easily interpreted. Nevertheless, new microarray data are still being generated and, together with their considerable legacy, can offer a complementary perspective on biological systems and disease pathogenesis. The challenge now is to exploit novel methods for enhancing and combining these data with those generated by alternative high-throughput techniques, such as sequencing, to provide added value. Augmentation and integration of microarray data and the new horizons this opens up, provide the theme for the papers in this Special Issue.

Indexed as

augmentationhigh-throughput genomic analysisintegrationmicroarray data typesmodeling gene expressionsequencing techniques

Identifiers

PMID27775644
PMCPMC5197945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.